0.6851

5.38% +0.035

After Hours: .68 -0.0051 -0.74%

Elevai Labs Inc (ELAB)

Overview News Price History Discussions Forecast

Elevai Labs Inc stock is currently priced at $0.6851, with a 24-hour trading volume of 144.51K. It has seen a +5.38% increased in the last 24 hours and a +19.67% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $0.6484 pivot point. If it approaches the $0.6867 resistance level, significant changes may occur.

Previous Close:

$0.6501

Open:

$0.657

24h Volume:

144.51K

Market Cap:

$11.87M

Revenue:

$1.44M

Net Income/Loss:

$-3.21M

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+5.40%

1M Performance:

+19.67%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1D Range:

$0.6511

$0.695

52W Range:

$0.5709

$4.2442

Elevai Labs Inc Stock (ELAB) Company Profile

Name

Elevai Labs Inc

Sector

Healthcare (1209)

Industry

Biotechnology (699)

Phone

866-794-4940

Address

120 Newport Center Drive, Suite 250, Newport Beach

Employee

Twitter

Next Earnings Date

Latest SEC Filings

ELAB's Discussions on Twitter

Elevai Labs Inc Stock (ELAB) Latest News

Wall Street Breakfast: The Week Ahead

Seeking Alpha

Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use I - Benzinga

Benzinga

Elevai Labs Inc. Reports First Quarter 2024 Financial Results - GlobeNewswire

GlobeNewswire

Elevai Labs Inc. Reports First Quarter 2024 Financial Results

GlobeNewswire Inc.

Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of ... - GlobeNewswire

GlobeNewswire

Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity

GlobeNewswire Inc.

Elevai Labs Inc Stock (ELAB) Financials Data

Elevai Labs Inc (ELAB) Revenue 2024

ELAB reported a revenue (TTM) of $1.44 million for the quarter ending September 30, 2023.

Elevai Labs Inc (ELAB) Net Income 2024

ELAB net income (TTM) was -$3.21 million for the quarter ending September 30, 2023.

Elevai Labs Inc (ELAB) Earnings per Share 2024

ELAB earnings per share (TTM) was -$0.1855 for the quarter ending September 30, 2023.

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.